Attached files

file filename
10-Q - 090930_IMSC_FORM 10Q - SECURE POINT TECHNOLOGIES INCimscform10q090930.htm
EX-32.1 - 090930_IMSC_FORM 10Q_EX 32.1 - SECURE POINT TECHNOLOGIES INCimscform10q090930_ex32-1.htm
EX-31.2 - 090930_IMSC_FORM 10Q_EX 31.2 - SECURE POINT TECHNOLOGIES INCimscform10q090930_ex31-2.htm
EX-31.1 - 090930_IMSC_FORM 10Q_EX 31.1 - SECURE POINT TECHNOLOGIES INCimscform10q090930_ex31-1.htm


Exhibit 32.2
 
 
In connection with the Quarterly Report of Implant Sciences Corporation, a Massachusetts corporation (the “Company”) on Form 10-Q for the period ended September 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Glenn D. Bolduc, President, Chief Executive Officer and Chief Financial Officer of we, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
 
(1)       The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)       The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of we.
 
 
/s/ Glenn D. Bolduc
 
Glenn D. Bolduc
 
President, Chief Executive Officer and Chief Financial Officer
Date: November 13, 2009
 

 

This certification accompanies each report of we on Form 10-Q and Form 10-K pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by we for purposes of §18 of the Securities Exchange Act of 1934, as amended.
 
A signed original of this written statement required by §906 has been provided to we and will be retained by we and furnished to the Securities and Exchange Commission or our staff upon request.